HEALTH● LOW1h ago · Sep 2, 2026, 4:15 AM
Telix Completes Enrollment in Phase 3 BiPASS Study , Aligns with FDA on NDA Pathway
singaporestar.com · Singapore · north america
Telix has finished enrolling participants for its Phase 3 BiPASS study and has coordinated with the FDA regarding the New Drug Application process, marking progress in drug development.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH51m agoBooze at young age linked to lasting brain changesEuroNews [en]HEALTH58m agoMan who refused to leave Great Western Hospital taken to courtswindonadvertiser.co.uk · United KingdomHEALTH58m agoFree Mental Health Care For All South Australiansmiragenews.com · United StatesHEALTH2h agoAndhra CM orders inquiry after villagers fall ill following anti-malaria drug distributionThe Hindu